Research Presentation Sessions: Interventional Radiology

Interventional management of malignant liver lesions

Lectures

1
Introduction by the moderator - Thomas K. Helmberger, Munich / DE

Introduction by the moderator - Thomas K. Helmberger, Munich / DE

02:00

2
Can microwave ablation of HCC modulate systemic inflammation and immunity? An analysis of factors affecting neutrophil-to-lymphocyte ratio and correlation with local tumour progression - Angelo Della Corte, Milan / IT

Can microwave ablation of HCC modulate systemic inflammation and immunity? An analysis of factors affecting neutrophil-to-lymphocyte ratio and correlation with local tumour progression - Angelo Della Corte, Milan / IT

08:00

3
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation - Lukas Müller, Mainz / DE

Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation - Lukas Müller, Mainz / DE

08:00

4
Laser-induced thermotherapy (LITT) versus microwave ablation (MWA) in hepatocellular carcinoma (HCC): therapy response and survival rates - Thomas J. Vogl, Frankfurt a. Main / DE

Laser-induced thermotherapy (LITT) versus microwave ablation (MWA) in hepatocellular carcinoma (HCC): therapy response and survival rates - Thomas J. Vogl, Frankfurt a. Main / DE

08:00

5
Treatment of primary and secondary liver tumours using microwave ablation (MWA): MR elastography as response parameter - Thomas J. Vogl, Frankfurt a. Main / DE

Treatment of primary and secondary liver tumours using microwave ablation (MWA): MR elastography as response parameter - Thomas J. Vogl, Frankfurt a. Main / DE

08:00

6
Radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC): CT texture analysis of the ablated area to predict local recurrence - Daniele Autelitano, Verona / IT

Radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC): CT texture analysis of the ablated area to predict local recurrence - Daniele Autelitano, Verona / IT

08:00

7
Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: evaluation of the CALLY index - Lukas Müller, Mainz / DE

Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: evaluation of the CALLY index - Lukas Müller, Mainz / DE

08:00

8
Augmented reality-guided percutaneous thermal ablation of small hepatic tumours: first clinical experience in human patients worldwide - Luigi Solbiati, Rozzano (Milano) / IT

Augmented reality-guided percutaneous thermal ablation of small hepatic tumours: first clinical experience in human patients worldwide - Luigi Solbiati, Rozzano (Milano) / IT

08:00

9
Comparison of combined chemoembolisation and microwave ablation with chemoembolisation alone in patients with hepatocellular carcinoma beyond the Milan criteria: a propensity scoring matching study - Yu-dong Xiao, Changsha / CN

Comparison of combined chemoembolisation and microwave ablation with chemoembolisation alone in patients with hepatocellular carcinoma beyond the Milan criteria: a propensity scoring matching study - Yu-dong Xiao, Changsha / CN

08:00

10
Does lipiodol retention pattern influence the treatment efficacy of computed tomography guided thermal ablation for hepatocellular carcinoma: a propensity scoring matching study - Yu-dong Xiao, Changsha / CN

Does lipiodol retention pattern influence the treatment efficacy of computed tomography guided thermal ablation for hepatocellular carcinoma: a propensity scoring matching study - Yu-dong Xiao, Changsha / CN

08:00